Ultra-potent dipeptide nootropic and prodrug of cycloprolylglycine that enhances cognition through BDNF/NGF upregulation, AMPA receptor modulation, and multicomponent neuroprotection at doses 1000 times lower than piracetam
Written by — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Oral: Taken by mouth as a capsule, tablet, or liquid.
Bioavailability Varies by compound — many peptides are largely broken down in the gut, so little reaches the blood intact; some small molecules absorb well.
10 mg twice daily (20 mg/day)
Frequency
Twice daily (morning and afternoon)
Duration
56 days (8 weeks) per clinical study
Dose used in a controlled human study of mild cognitive impairment, improving cognition with good tolerability .
Timing
Best time to take
Take Noopept (Omberacetam) at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.
With food?
Noopept (Omberacetam) can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.
If stacking
Noopept (Omberacetam) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
You've tolerated the current dose for the recommended period without significant side effects
Therapeutic goals haven't been met at the current dose level
Your healthcare provider recommends dose escalation based on your response
Lab work or clinical assessments support a higher dose
Decrease if
Side effects are bothersome or impacting daily life despite management strategies
You experience any signs of an adverse reaction
Lab results indicate the need for dose reduction
Your healthcare provider recommends a lower dose based on your response
Signs of right dose
Therapeutic goals being met with minimal side effects
Stable and consistent response to treatment
Lab values or clinical markers trending in the right direction
Good tolerance with manageable or absent side effects
Administration
How do I use Noopept (Omberacetam)?
Reconstitution
What you need
Noopept (Omberacetam) in its prescribed form
Clean, dry storage container
Measuring device if applicable (oral syringe, measuring cup)
Calendar or reminder app for dosing schedule
Injection
Route
Noopept (Omberacetam) is administered Oral (tablet/capsule)—no injection required
Best sites
location_onNot applicable—this is not an injectable formulation
Storage
Before reconstitution
Store Noopept (Omberacetam) in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Noopept (Omberacetam) should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
warningSigns of degradation — discard the vial
Solution appears cloudy, discolored, or contains visible particles (should be clear)
Product has been exposed to temperatures outside the recommended storage range
Product has been frozen (unless specifically designed for freeze-thaw stability)
Expiration date has passed or reconstituted solution has exceeded its use-by date
Unusual odor, color change, or visible contamination
Sample daily schedule
As prescribed (multiple times daily)
As prescribed by your healthcare provider injection
Site: Oral (tablet/capsule)—rotate sites if applicable
Maintain a consistent schedule for optimal results with Noopept (Omberacetam). Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Severe or worsening side effects that don't improve with dose adjustment or supportive care
Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
Your healthcare provider recommends discontinuation based on your clinical response
Development of any new medical condition that may be contraindicated with Noopept (Omberacetam)
Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
Abnormal lab results or clinical markers that suggest adverse effects
Noopept (Omberacetam) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
warningFlagged pairings
High-dose racetams simultaneously — overlapping mechanisms may cause overstimulation or diminishing returns — Use with caution—discuss with your healthcare provider.
Strong glutamatergic agents or AMPA potentiators — risk of excitatory overload through shared AMPA receptor modulation — Use with caution—discuss with your healthcare provider.
Anticholinergic medications — may counteract Noopept's cholinergic-positive effects — Use with caution—discuss with your healthcare provider.
Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation
This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.
GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons
Pelsman A, Hoyo-Vadillo C, Gudasheva TA · 2003PubMed
This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.
Noopept efficiency in experimental Alzheimer disease: cognitive deficiency caused by beta-amyloid25-35 injection into Meynert basal nuclei of rats
Ostrovskaya RU, Belnik AP, Storozheva ZI · 2008PubMed
This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.
Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept) — an active pharmaceutical ingredient with nootropic activity
Araj SK, Szeleszczuk Ł, Gubica T · 2025PubMed
This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.
Behavioral and electrophysiological analysis of the choline-positive effect of nootropic dipeptide acylproline (GVS-111)
Ostrovskaya RU, Mirzoev TKh, Firova FA · 2001PubMed
This study investigated the properties and effects of Noopept (Omberacetam), contributing to our understanding of its mechanism of action and potential therapeutic applications.